Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 13/20 | 0.75 |
| ▸ | PPARD | Q03181 | 8/20 | 0.75 |
| ▸ | PPARG | P37231 | 1/20 | 0.75 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | KRAS | P01116 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13359231 | 0.90 | PPARA (0.78) | PPARAPPARDPPARGKCNH2 | |
| SCHEMBL13764697 | 0.89 | PPARA (0.77) | PPARAPPARDPPARGKCNH2 | |
| SCHEMBL15163347 | 0.89 | PPARA (0.77) | PPARAPPARDPPARGKCNH2 | |
| SCHEMBL12463781 | 0.88 | PPARA (0.72) | PPARAPPARDPPARGKCNH2 | |
| SCHEMBL814805 | 0.88 | PPARA (0.75) | PPARAPPARDPPARGKCNH2KRAS | |
| SCHEMBL13764701 | 0.88 | PPARA (0.75) | PPARAPPARDPPARGKCNH2 | |
| SCHEMBL21897758 | 0.88 | PPARA (0.75) | PPARAPPARDPPARGKCNH2 | |
| SCHEMBL814530 | 0.88 | PPARA (0.75) | PPARAPPARDPPARGKCNH2 | |
| SCHEMBL12464057 | 0.87 | PPARA (0.71) | PPARAPPARDPPARGKCNH2 | |
| SCHEMBL13764710 | 0.87 | PPARA (0.58) | PPARAPPARDPPARGKCNH2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7566737-B2 | Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients | GENFIT (FR) | 2009-07-28 | — | — | US | disclosed |
| US-7566737-B2 | Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients | GENFIT (FR) | 2009-07-28 | — | — | US | disclosed |
| US-20070032543-A1 | Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients | GENFIT (FR) | 2007-02-08 | — | — | US | disclosed |
| US-20070032543-A1 | Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients | GENFIT (FR) | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032543-A1 | Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients | PSEN1, BACE1, PSEN2 | PPARA 69/4885PPARD 39/4885PPARG 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.